Multi-omics analysis of Helicobacter pylori –associated gastric cancer identifies hub genes as a novel therapeutic biomarker
Briefings in Bioinformatics · 01.05.2025 · 26 (3)
DOI: 10.1093/bib/bbaf241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 30.05.2025. Verfasst von Sara H Mohamed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Egyptian Drug Authority (EDA), formerly National Organization for Drug Control and Research (NODCAR), Giza 14281, Egypt. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections, Biomarkers, Tumor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DAAD Ta'ziz project GJRC-IH: German-Jordanian Research Cluster in Intelligent Healthcare Informatics, GARN-CLS: German Arab Research Network for Computational Life Science, DAAD Ta’ziz project GJRC-IH: German-Jordanian Research Cluster in Intelligent Healthcare Informatics.
Abstract (Originalsprache)
Helicobacter pylori infection is one of the most common gastric pathogens; however, the molecular mechanisms driving its progression to gastric cancer remain poorly understood. This study aimed to identify the key transcriptomic drivers and therapeutic targets of H. pylori–associated gastric cancer through an integrative transcriptomic analysis. This analysis integrates microarray and RNA-seq datasets to identify significant differentially expressed genes (DEGs) involved in the progression of H. pylori–associated gastric cancer. In addition to independent analyses, data were integrated using ComBat to detect consistent expression patterns of hub genes. This approach revealed distinct clustering patterns and stage-specific transcriptional changes in common DEGs across disease progression, including H. pylori infection, gastritis, atrophy, and gastric cancer. Genes such as TPX2, MKI67, EXO1, and CTHRC1 exhibited progressive upregulation from infection to cancer, highlighting involvement in cell cycle regulation, DNA repair, and extracellular matrix remodeling. These findings provide insights into molecular shifts linking inflammation-driven infection to malignancy. Furthermore, network analysis identified hub genes, including CXCL1, CCL20, IL12B, and STAT4, which are enriched in immune pathways such as chemotaxis, leukocyte migration, and cytokine signaling. This emphasizes their role in immune dysregulation and tumor development. Expression profiling demonstrated the upregulation of hub genes in gastric cancer and stage-specific changes correlating with disease progression. Finally, drug–gene interaction analysis identified therapeutic opportunities, with hub genes interacting with approved drugs like abatacept and zoledronic acid, as well as developmental drugs such as adjuvant and relapladib. These findings highlight the key role of these hub genes as biomarkers and therapeutic targets, providing a foundation for advancing precision medicine in H. pylori–associated gastric cancer. Overall, this study paves the way for advancing precision medicine in H. pylori–associated gastric cancer by providing insights into the development of early detection biomarkers, risk stratification, and targeted therapies. This supports the clinical translation of precision medicine strategies in H. pylori–associated gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Egyptian Drug Authority (EDA), formerly National Organization for Drug Control and Research (NODCAR), Giza 14281, Egypt.
- Institute for Biostatistics and Informatics in Medicine and Ageing Research (IBIMA), Rostock University Medical Center, Rostock 18057, Germany.
- Faculty of Media Engineering and Technology, German University in Cairo, Cairo 11835, Egypt.
- Radiation Oncology Department, Oncology Center in East Jeddah Hospital (Jeddah First Health Cluster), Rabigh, Saudi Arabia.
- Center of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
ORCID-Profile: Sara H Mohamed, Mohamed Hamed, Fadhl M Alakwaa, Asmaa Reda
Förderung
- DAAD Ta'ziz project GJRC-IH: German-Jordanian Research Cluster in Intelligent Healthcare Informatics
- GARN-CLS: German Arab Research Network for Computational Life Science
- DAAD Ta’ziz project GJRC-IH: German-Jordanian Research Cluster in Intelligent Healthcare Informatics
Zitieren
APA
Mohamed, S. H., Hamed, M., Alamoudi, H. A., Jastaniah, Z., Alakwaa, F. M., & Reda, A. (2025). Multi-omics analysis of Helicobacter pylori –associated gastric cancer identifies hub genes as a novel therapeutic biomarker. Briefings in Bioinformatics, 26(3). https://doi.org/10.1093/bib/bbaf241
Vancouver
Mohamed SH, Hamed M, Alamoudi HA, Jastaniah Z, Alakwaa FM, Reda A. Multi-omics analysis of Helicobacter pylori –associated gastric cancer identifies hub genes as a novel therapeutic biomarker. Briefings in Bioinformatics. 2025;26(3). doi:10.1093/bib/bbaf241
BibTeX
@article{Mohamed2025,
author = {Mohamed, Sara H and Hamed, Mohamed and Alamoudi, Hussain A and Jastaniah, Zayd and Alakwaa, Fadhl M and Reda, Asmaa},
title = {Multi-omics analysis of Helicobacter pylori –associated gastric cancer identifies hub genes as a novel therapeutic biomarker},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {3},
doi = {10.1093/bib/bbaf241}
}
EUVIMED